Guangdong Association Of Clinical Trials

This study is for people with stage II-IIIB non-small cell lung cancer who have had surgery after initial treatment with immunotherapy and chemotherapy. It tests whether using a sensitive blood test (called MRD) to detect tiny amounts of leftover cancer can help decide who needs …

This study is testing whether a new combination of two drugs (IBI351 and cetuximab β) can help control advanced lung cancer in people who have not yet received treatment and have a specific genetic change called KRAS G12C. The trial will enroll 48 adults to see how well the tumor…

This study is for people with advanced non-small cell lung cancer who have a specific genetic change (EGFR mutation). It tests if adding a second drug (sacituzumab tirumotecan) to their current medication (osimertinib) helps control the cancer better. The decision to add the seco…